ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.

The ESHAP regimen, a combination of the chemotherapeutic drugs etoposide, methylprednisolone (solumedrol), high-dose cytarabine (ara-C), and cisplatin, has been shown to be active against refractory or relapsed non-Hodgkin's lymphoma (NHL) in therapeutic trials. We undertook this study to deter...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Choi, Chul Won, Paek, Chang Won, Seo, Jae Hong, Kim, Byung Soo, Shin, Sang Won, Kim, Yeul Hong, Kim, Jun Suk
Formato: Artigo
Idioma:Inglês
Publicado: Korean Academy of Medical Sciences 2002
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3054931/
https://ncbi.nlm.nih.gov/pubmed/12378012
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares